Vor Bio (Nasdaq: VOR), a clinical-stage biotechnology company transforming the treatment of autoimmune diseases, today announced that, on July 1, 2026, the Compensation ...

Alex Ovechkin has made a decision about his playing future. It's big news for D.C.

Officials will hold two events featuring facilitated roundtable discussions to guide the development of the ordinance, according to a press release. × This page requires Javascript. Javascript is ...

Customizing your browser to hide often makes it easier to recognize.

Peter Gratton, Ph.D., is a New Orleans-based editor and professor with over 20 years of experience in investing, economics, and public policy. Peter began covering markets at Multex (Reuters) and has ...

We independently evaluate all of our recommendations. If you click on links we provide, we may receive compensation. Learn what it takes to trade options Gordon Scott has been an active investor and ...